Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
mirvetuximab soravtansine
×
30 days
×
Clear all
Filters
3
NCT05445778
2026-02-23
GLORIOSA
AbbVie
Phase 3
Recruiting
520 enrolled